1,969
Views
1
CrossRef citations to date
0
Altmetric
Rheumatology

A budget impact analysis for making treatment decisions based on anti-cyclic citrullinated peptide (anti-CCP) testing in rheumatoid arthritis

, , , &
Pages 624-630 | Received 13 Jan 2020, Accepted 17 Feb 2020, Published online: 19 May 2020